SSWM
GHDX

Sheets Smith Wealth Management’s Genomic Health, Inc. GHDX Stock Holding History

Sheets Smith Wealth Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,632
Closed -$536K – 344
2018
Q3 		$536K Buy
7,632
+92
+1% +$5.38K 0.11% 208
2018
Q2 		$380K Buy
+7,540
New +$299K 0.09% 235

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sheets Smith Wealth Management's GHDX Position: Q4 2018 in Review

Sheets Smith Wealth Management sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 7,632 shares — an estimated $536K sold.

Sheets Smith Wealth Management first reported a position in GHDX in Q2 2018 and held it in 2 quarters. The position peaked at $536K in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • Sheets Smith Wealth Management reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 7,632 Genomic Health, Inc. shares in Q4 2018, an estimated $536K.
  • Sheets Smith Wealth Management first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 2 quarters.
  • Sheets Smith Wealth Management's Genomic Health, Inc. position peaked at $536K in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on Sheets Smith Wealth Management's 13F filing for Q4 2018, filed 11 Jan 2019.